These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies - a mini review. Singer W Clin Auton Res; 2022 Aug; 32(4):291-297. PubMed ID: 35895157 [TBL] [Abstract][Full Text] [Related]
4. Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies. Palermo G; Del Prete E; Bonuccelli U; Ceravolo R J Neurol; 2020 Dec; 267(12):3444-3456. PubMed ID: 32594302 [TBL] [Abstract][Full Text] [Related]
5. Diagnosing multiple system atrophy at the prodromal stage. Xia C; Postuma RB Clin Auton Res; 2020 Jun; 30(3):197-205. PubMed ID: 32232688 [TBL] [Abstract][Full Text] [Related]
7. α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward. Bellomo G; De Luca CMG; Paoletti FP; Gaetani L; Moda F; Parnetti L Neurology; 2022 Aug; 99(5):195-205. PubMed ID: 35914941 [TBL] [Abstract][Full Text] [Related]
8. Infectious Agents as Potential Drivers of α-Synucleinopathies. Linard M; Ravier A; Mougué L; Grgurina I; Boutillier AL; Foubert-Samier A; Blanc F; Helmer C Mov Disord; 2022 Mar; 37(3):464-477. PubMed ID: 35040520 [TBL] [Abstract][Full Text] [Related]
9. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042 [TBL] [Abstract][Full Text] [Related]
10. Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies. Labbé C; Ogaki K; Lorenzo-Betancor O; Soto-Ortolaza AI; Walton RL; Rayaprolu S; Fujioka S; Murray ME; Heckman MG; Puschmann A; McCarthy A; Lynch T; Siuda J; Opala G; Rudzinska M; Krygowska-Wajs A; Barcikowska M; Czyzewski K; Sanotsky Y; Rektorová I; McLean PJ; Rademakers R; Ertekin-Taner N; Hassan A; Ahlskog JE; Boeve BF; Petersen RC; Maraganore DM; Adler CH; Ferman TJ; Parisi JE; Graff-Radford NR; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA Neurology; 2015 Nov; 85(19):1680-6. PubMed ID: 26333800 [TBL] [Abstract][Full Text] [Related]
11. The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies. Leys F; Wenning GK; Fanciulli A Neurol Sci; 2022 Jan; 43(1):187-198. PubMed ID: 34817726 [TBL] [Abstract][Full Text] [Related]
12. Analysis of Protein Conformational Strains-A Key for New Diagnostic Methods of Human Diseases. Surguchov A Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316500 [TBL] [Abstract][Full Text] [Related]
13. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Spillantini MG; Goedert M Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145 [TBL] [Abstract][Full Text] [Related]
14. Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions. Walker L; Stefanis L; Attems J J Neurochem; 2019 Sep; 150(5):467-474. PubMed ID: 30892688 [TBL] [Abstract][Full Text] [Related]
15. Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy. Kao AW; Racine CA; Quitania LC; Kramer JH; Christine CW; Miller BL Alzheimer Dis Assoc Disord; 2009; 23(4):365-70. PubMed ID: 19935145 [TBL] [Abstract][Full Text] [Related]
16. 'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies? Udow SJ; Robertson AD; MacIntosh BJ; Espay AJ; Rowe JB; Lang AE; Masellis M J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1311-1321. PubMed ID: 27613160 [TBL] [Abstract][Full Text] [Related]